Literature DB >> 21636162

Uric acid and mortality from all-causes and cardiovascular disease among adults with and without diagnosed diabetes: findings from the National Health and Nutrition Examination Survey III Linked Mortality Study.

Earl S Ford1.   

Abstract

Using data from the National Health and Nutrition Examination Survey III Linked Mortality Study, uric acid concentration was significantly related to mortality from all-causes (978 diabetic participants: hazard ratio per mg/dl, 1.14; 95% confidence interval, 1.01-1.28; 12,824 nondiabetic participants: hazard ratio, 1.06; 95% confidence interval, 1.02-1.11) but not major CVD.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636162     DOI: 10.1016/j.diabres.2011.05.012

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  The effects of mammalian target of rapamycin inhibitors on serum uric acid levels in renal transplant patients.

Authors:  Ozkan Gungor; Mehmet Tanrisev; Fatih Kircelli; Mehmet Nuri Turan; Cem Tugmen; Erhan Tatar; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-06-30       Impact factor: 2.370

2.  Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes.

Authors:  Lian-Xi Li; Xue-Hong Dong; Mei-Fang Li; Rong Zhang; Ting-Ting Li; Juan Shen; Jing Shen; Yu-Qian Bao; Wei-Ping Jia
Journal:  J Hypertens       Date:  2015-03       Impact factor: 4.844

3.  Comparison of the effects of metoprolol or carvedilol on serum gamma-glutamyltransferase and uric acid levels among patients with acute coronary syndrome without ST segment elevation.

Authors:  Lütfü Aşkın; Şule Karakelleoğlu; Hüsnü Değirmenci; Selami Demirelli; Ziya Şimşek; Muhammed Hakan Taş; Selim Topçu; Zakir Lazoğlu
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

4.  Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants.

Authors:  Fatemeh Rahimi-Sakak; Mahsa Maroofi; Jamal Rahmani; Nick Bellissimo; Azita Hekmatdoost
Journal:  BMC Cardiovasc Disord       Date:  2019-10-15       Impact factor: 2.298

5.  Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.

Authors:  Inger L Meek; Harald E Vonkeman; Mart Afj van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2014-05-23       Impact factor: 2.362

6.  Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.

Authors:  Victor C Kok; Jorng-Tzong Horng; Wan-Shan Chang; Ya-Fang Hong; Tzu-Hao Chang
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.